Acadia Pharmaceuticals (ACAD) Current Taxes (2022 - 2024)

Acadia Pharmaceuticals (ACAD) posted quarterly Current Taxes of $8.5 million for Q2 2024, up 11.4% quarter-over-quarter from $7.6 million in Q1 2024.

Acadia Pharmaceuticals (ACAD) Current Taxes (2022 - 2024) Analysis & Trends

Acadia Pharmaceuticals' Current Taxes history runs 3 years deep, the most recent figure standing at $8.5 million for Q2 2024.

In Q2 2024, Current Taxes changed N/A year-over-year to $8.5 million; the TTM figure through Jun 2024 stood at $8.5 million (changed N/A YoY), while the FY2023 annual figure was $8.7 million, up 2210.34% from the prior year.
Current Taxes for Q2 2024 stood at $8.5 million, up from $7.6 million in the prior quarter.
The five-year high for Current Taxes was $8.7 million in Q4 2023, with the low at $377000.0 in Q4 2022.
The 3-year median for Current Taxes is $8.5 million (2023), against an average of $6.7 million.
Peak annual rise in Current Taxes reached 2210.34% in 2023, while the deepest fall reached 2210.34% in 2023.
Acadia Pharmaceuticals' Current Taxes stood at $377000.0 in 2022, then surged by 2210.34% to $8.7 million in 2023, then slipped by 2.92% to $8.5 million in 2024.
Business Quant data shows ACAD's Current Taxes at $8.5 million in Q2 2024, $7.6 million in Q1 2024, and $8.7 million in Q4 2023.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Current Taxes (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn	-
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn	49.00 Mn
4	Revolution Medicines	43.64 Bn	43.64 Bn	-	-
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn	76.32 Mn
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn	59,089.99
7	Royalty Pharma	33.72 Bn	35.84 Bn	-	-
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn	-
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn	-
10	Acadia Pharmaceuticals	4.86 Bn	3.90 Bn	279.64 Mn	-

Download Data